StockTipsArenaBeta

BUY Mankind Pharma Limited — Sahi Research

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

bySahi ResearchHorizon: NA (inferred Swing (≤2wk))28 Jul 2026via Sahi Research Telegram

Entry₹2,574.5Stated
Target₹2,690
Total upside +4.49% (call closed)
Stop loss₹2,500-2.89% risk
Exit₹2,50031 Jul 2026, 9:15 am
Stop-loss hit-2.89%
Follow Sahi Research for new calls(29% target hit, 122 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Jul 2026
5 supporting1 neutral0 opposing
Supports the BUY call (5)

Mankind Pharma Q1 profit rises 30%, margins expand on strong domestic business

NewsCnbc-Tv18·30 Jul · today

(opens in new tab)

Mankind Pharma announced strong Q1FY27 financial results with a 13% YoY revenue growth to INR 4,031 Crore and a 25% YoY EBITDA growth to INR 1,060 Crore. PAT grew by 29% YoY. The company highlighted d

BSE · Company Update·30 Jul · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·29 Jul · 2d ago

Mankind Pharma completes sale of Broadway Hospitality stake for ₹49 crore

NewsGoogle News·27 Jul · 3d ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Jul · 3w ago

Neutral / worth noting (1)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Sahi Research

Every call and its outcome